Showing results (221-230 of 236) with videos related to

Sort By:
Pageof 24
The Lancet. Gastroenterology & Hepatology|October 10, 2024
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 studyMan-Fung Yuen, Young-Suk Lim, Ki Tae Yoon, et al.
Cancers|June 26, 2025
Roadmap for HCC Surveillance and Management in the Asia PacificMasatoshi Kudo, Bui Thi Oanh, Chien-Jen Chen, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 26, 2021
Identification of microRNA-96-5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinomaTakeshi Matsui, Susumu Hamada-Tsutsumi, Yutaka Naito, et al.
Hepatology Communications|October 4, 2022
Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis BMan-Fung Yuen, Elina Berliba, Wattana Sukeepaisarnjaroen, et al.
Antiviral Research|October 13, 2024
Circulating capsid-antibody-complexes (CACs) drive intrahepatic complement deposition and inform subclinical liver inflammation in chronic hepatitis BYijie Tang, Mingzhu Xu, Cong Wang, et al.
Plos Computational Biology|January 9, 2025
Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markersKwang Su Kim, Masashi Iwamoto, Kosaku Kitagawa, et al.
JHEP Reports : Innovation in Hepatology|October 18, 2021
Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa studyHaiyan Ma, Tien Huey Lim, Apinya Leerapun, et al.
Nature Communications|May 22, 2026
Angptl4 integrates dietary and microbial signals to disrupt gut barrier function in MASHDamien Chua, Zun Siong Low, Joseph Han Sol Kim, et al.
The Lancet. Gastroenterology & Hepatology|May 22, 2026
The small interfering RNA imdusiran as single and multiple doses in healthy, randomised individuals and non-randomised individuals with chronic hepatitis B (AB-729-001): a phase 1a/b trialMan-Fung Yuen, Edward Gane, Jacinta A Holmes, et al.
Nature Medicine|November 7, 2025
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trialGrace Lai-Hung Wong, Man-Fung Yuen, Bingliang Lin, et al.
Pageof 24